JFG
ORKA

Jefferies Financial Group’s Oruka Therapeutics ORKA Stock Holding History

Jefferies Financial Group’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-64,991
Closed -$1.25M – 2116
2025
Q3 		$1.25M Hold
64,991
– – 0.01% 793
2025
Q2 		$729K Sell
64,991
-340,038
-84% -$3.54M 0.01% 814
2025
Q1 		$4.16M Buy
405,029
+55,000
+16% +$686K 0.04% 346
2024
Q4 		$6.79M Buy
+350,029
New +$8.54M 0.04% 290

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Jefferies Financial Group's ORKA Position: Q4 2025 in Review

Jefferies Financial Group sold out of Oruka Therapeutics (ORKA) in Q4 2025, closing a stake of 64,991 shares — an estimated $1.25M sold.

Jefferies Financial Group first reported a position in ORKA in Q4 2024 and held it in 4 quarters. The position peaked at $6.79M in Q4 2024. 143 funds tracked by Wall St. Rank hold ORKA as of Q4 2025.

  • Jefferies Financial Group reported no remaining Oruka Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Jefferies Financial Group sold 64,991 Oruka Therapeutics shares in Q4 2025, an estimated $1.25M.
  • Jefferies Financial Group first reported a position in Oruka Therapeutics in Q4 2024 and held it in 4 quarters.
  • Jefferies Financial Group's Oruka Therapeutics position peaked at $6.79M in Q4 2024.
  • 143 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q4 2025.

Based on Jefferies Financial Group's 13F filing for Q4 2025, filed 9 Feb 2026.